The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
PZA | |
Gain YTD | 0.386 |
Net Assets | 3.14B |
Total Expense Ratio | 0.28 |
Turnover | 4.00 |
Yield | 3.55 |
Fund Existence | 18 years |
PZA | |
---|---|
RSI ODDS (%) | 1 day ago41% |
Stochastic ODDS (%) | 1 day ago48% |
Momentum ODDS (%) | 1 day ago52% |
MACD ODDS (%) | 1 day ago45% |
TrendWeek ODDS (%) | 1 day ago50% |
TrendMonth ODDS (%) | 1 day ago44% |
Advances ODDS (%) | 1 day ago53% |
Declines ODDS (%) | 15 days ago63% |
BollingerBands ODDS (%) | 1 day ago40% |
Aroon ODDS (%) | 1 day ago42% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
EVLU | 30.27 | 0.33 | +1.09% |
iShares MSCI Emerging Mkts Val Fac ETF | |||
FMED | 24.42 | 0.03 | +0.14% |
Fidelity Disruptive Medicine ETF | |||
GAPR | 39.12 | N/A | +0.01% |
FT Vest U.S. Eq Mod Buf ETF - Apr | |||
IGRO | 79.75 | -0.05 | -0.07% |
iShares International Dividend Gr ETF | |||
INCE | 59.00 | -0.10 | -0.17% |
Franklin Income Equity Focus ETF |
A.I.dvisor tells us that PZA and NIQ have been poorly correlated (+-6% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PZA and NIQ's prices will move in lockstep.